Sopharma AD plans to build the new lyophilic factory in Sofia in the first half of 2018. With the construction of the plant Sopharma AD will double the capacity of its current production facilities, which will ensure the production of sufficient quantities of the life-saving hospital product Methylprednisolone and will create additional workplaces.

Sopharma AD notifies that for December 2017 the Company recorded an increase of sales revenues of 21% compared to the same month of 2016, including 73% increase of domestic sales and 4% increase of export sales.

For 2017, revenues from sales increased by 13% compared to 2016, including 3% increase of domestic sales and a 20% increase of export sales.